Stenabolic raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-02-01 and is reviewed periodically as new material appears.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Research-use-only status in many markets |
| WADA status | Prohibited in sport | Generally listed as a non-approved substance |
| Detection technique | LC-MS/MS | Common for urine and blood analysis |
| Common alias | Stenabolic | Informal market nickname, not a pharmacopoeial name |
| Purity check | HPLC or LC-UV | Independent certificate of analysis is typical |
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
=== Enzyme substitutes === In 2018, the FDA approved an enzyme substitute called pegvaliase which metabolizes phenylalanine. It is for adults who are poorly managed on other treatments. Tetrahydrobiopterin (BH4) (a cofactor for the oxidation of phenylalanine) when taken by mouth can reduce blood levels of this amino acid in some people.
== Research and career == Parsons joined King's College London as a Royal Society University Research Fellow in 2005. She was promoted to Reader in 2013, and Professor in 2015. Parsons investigates the fundamental mechanisms that drive cell adhesion and migration using microscopy, molecular biology and three-dimensional simulations. She uses a confocal super-resolution microscope and Total internal reflection fluorescence microscope to image dynamic events over long periods. Whilst adhesion is critical to normal cellular function (e.g. development and homeostasis), it also drives cancer and fibrosis. In particular, Parsons focuses on integrins, and their behaviour in the extracellular matrix. By comparing "normal" cells with cancer cells, Parsons identified that the likelihood of cell invasion depended on the duration and chemistry of their adhesion with the matrix. Beyond fundamental cellular processes, Parsons has studied wound healing and inflammation using skin and lung epithelial cells. Parsons founded UKRI Technology Touching Life Integrated Biological Imaging Network, a multi-university, multidisciplinary research effort focussed on the development of strategies to understand and combat human disease. The network looks to understand the signalling hierarchy of cell adhesion, the molecular cues that regulate cell behaviour and the tissue mechanics that control cell growth. In 2017, Parsons was appointed to the executive committee of the Royal Microscopical Society. She is Editor in Chief of The International Journal of Biochemistry & Cell Biology.
Patellamide A is a peptide natural product produced by Prochloron didemni, a cyanobacterial symbiont of Lissoclinum patella, and was first isolated in 1981. Patellamide A is one of many didemnid peptides. Other closely related peptides include patellamides B, C, and D and trunkamide. The patellamides and trunkamide show moderate cytotoxicity and activity against multidrug resistant cancer cell lines.
== Career == As a high-school student, Wolpaw wrote two games for the Atari 8-bit computers published as type-in programs in Antic magazine in 1983 and 1984. From 1997 to 2002, Wolpaw and Chet Faliszek wrote the video game-oriented website Old Man Murray. The site was highly influential in video game writing and game journalism. He also wrote for GameSpot. He subsequently worked at Double Fine Productions as a writer for Psychonauts. In 2006, he won the Game Developers Choice Award for Best Writing for his story and dialogue contributions to Psychonauts. In 2004, Wolpaw joined Valve, where he and Faliszek wrote for games such as Half-Life 2: Episode One, Half-Life 2: Episode Two, Team Fortress 2, Left 4 Dead, Portal and Portal 2. He left Valve in February 2017 to write for Psychonauts 2, though he ended up not working on it. In January 2019, he confirmed that he had returned to Valve as a part-time contractor on Artifact and Half-Life: Alyx.
Sources: en.wikipedia.org
The Augustus of Prima Porta (Italian: Augusto di Prima Porta) is a full-length portrait statue of Augustus, the first Roman emperor. The statue was discovered on April 20, 1863, during archaeological excavations directed by Giuseppe Gagliardi at the Villa of Livia owned by Augustus's third and final wife, Livia Drusilla in Prima Porta. Livia had retired to the villa after Augustus's death in AD 14. Its discovery was first publicized by the German archaeologist Wilhelm Henzen the same year. The marble statue was carved in the 1st century AD by skilled sculptors who may have been Greek, although this is not certain. The piece is generally believed to be a copy of a lost bronze original displayed in Rome. It blends Greek and Roman elements to craft an idealized official image of Augustus, showcasing his grasp of visual influence. While the head portrays a realistic youthful Augustus, the body diverges from reality; despite its clothed form, the body's stance reflects the heroic stance found in Greek statues. The detailed armor, depicting a Parthian returning standards to a Roman, symbolizes peace along the eastern frontier of the Roman Empire. The statue stands 2.08 metres (6 ft 10 in) tall and weighs 1,000 kilograms (2,200 lb). The Augustus of Prima Porta is now displayed in the Braccio Nuovo (New Arm) of the Vatican Museums. Since its discovery, it has become the best known of Augustus's portraits and one of the most famous sculptures of the ancient world.
=== Effects on nontarget species === Some insecticides kill or harm other creatures in addition to those they are intended to kill. For example, birds may be poisoned when they eat food that was recently sprayed with insecticides or when they mistake an insecticide granule on the ground for food and eat it. Sprayed insecticide may drift from the area to which it is applied and into wildlife areas, especially when it is sprayed aerially.
They rendezvous with local Interpol agent Gail Runciter and proceed to the safehouse, where an elderly Zola, in a wheelchair and requiring an oxygen mask, seemingly overpowers Kate Neville's telepathy with his evil visions of destruction. Runciter lures Fury away from the group and shocks him with a device before revealing herself to be Viper in disguise. She then kisses Fury with poisoned lipstick, leaving him unconscious, enabling Hydra to retake Zola. Fury learns he has 48 hours to live unless he can recover a sample of Viper's DNA from which to develop an antidote. Hydra threatens to attack Manhattan with the virus, barring payment of US $1 billion, and as proof of their threat, the real Gail Runciter is found, dying from the virus. After Fury and his team brief the President of the United States, Pierce determines from a chip from a laptop sold in the Aleutian Islands that the Hydra base might be there. Fury has his people split into two teams, one led by de Fontaine heading to Manhattan to find the refrigerated truck they believe will be needed to deploy the virus, and the other with Fury leading Pierce and Neville to the Aleutian Islands. Upon arriving in the Aleutian Islands and confirming that a Hydra transmission has come from there, Fury's plane is shot down by heat-seeking missiles. In Manhattan, de Fontaine's team figures out that the refrigerator truck is disguised as a garbage truck, while Fury and his team, having bailed out of the airplane in time, infiltrate the Hydra base.
Sources: en.wikipedia.org
Raising Cane's Restaurants, LLC, doing business as Raising Cane's Chicken Fingers (commonly referred to as Raising Cane's or Cane's), is an American fast-food chain specializing in chicken fingers. As of 2025, Raising Cane's is ranked third in annual sales for quick-serve chicken chains, behind Chick-fil-A and Popeyes.
== Passport power == The Henley Passport Index 2019 measures how many nations a given passport can enter without a visa. It ranks 190 nations on the "strength" of its passport. Thailand was ranked 68 of 190 countries (1=strong passport; 190=weak passport). A Thai passport can gain entry to 75 nations visa free. Other ASEAN nations ranked were: Singapore, 2/189 countries visa-free; Malaysia, 12/179; Brunei, 21/165; Indonesia, 72/71; Philippines, 74/66; Cambodia, 84/54; Laos, 86/52; Vietnam, 87/51; Myanmar, 90/48. Arton Capital's Passport Index 2017 ranks 193 member nations of the UN, as well as six territories, a total of 199 passport-issuing entities, on the number of countries a given passport can enter either visa-free (VF) or with a visa on arrival (VOA). Thailand ranked 107th of 199 nations in the number of VF/VOA countries granting its citizens visa-less entry (1=most passport power; 199=least passport power). Other ASEAN nations ranked were Singapore, 3; Malaysia, 19; Brunei, 49; Philippines, 127; Indonesia, 137; Cambodia, 154; Vietnam, 159; Laos, 169; and Myanmar, 180. The Passport Index also ranks countries by the number of countries to which they extend VF or VOA visas, a "Welcoming Index". Thailand ranked 62nd of 104 nations (due to numerous ties) (1=most countries granted VF or VOA entry; 104=fewest countries granted VF or VOA entry). Other ASEAN nations ranked were Cambodia, 1; Laos, 15; Indonesia, 16; Malaysia, 17; Singapore, 18; Philippines, 19; Brunei, 70; Vietnam, 83; Myanmar, 96.
== Prevention == Methods in preventing amputation, limb-sparing techniques, depend on the problems that might cause amputations to be necessary. Chronic infections, often caused by diabetes or decubitus ulcers in bedridden patients, are common causes of infections that lead to gangrene, which, when widespread, necessitates amputation. There are two key challenges: first, many patients have impaired circulation in their extremities, and second, they have difficulty curing infections in limbs with poor blood circulation. Crush injuries where there is extensive tissue damage and poor circulation also benefit from hyperbaric oxygen therapy (HBOT). The high level of oxygenation and revascularization speed up recovery times and prevent infections. A study found that the patented method called Circulator Boot achieved significant results in prevention of amputation in patients with diabetes and arteriosclerosis. Another study found it also effective for healing limb ulcers caused by peripheral vascular disease. The boot checks the heart rhythm and compresses the limb between heartbeats; the compression helps cure the wounds in the walls of veins and arteries, and helps to push the blood back to the heart. For victims of trauma, advances in microsurgery in the 1970s have made replantation of severed body parts possible. The establishment of laws, rules, and guidelines, and the employment of modern equipment help protect people from traumatic amputations.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.
Anti-doping laboratories typically use LC-MS/MS to detect SR9009 or its metabolites in urine or blood. The exact assay depends on the laboratory and the testing program. Detection can be challenging because the compound may be rapidly metabolized and present at low levels.
Stenabolic is an informal nickname used in online fitness and research-chemical markets, not an official drug name. It likely references reported effects on endurance in rodent studies. The nickname does not imply approval or proven human benefit.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.